← Leaderboards
James K Rowlett
Harvard University (Medical School)
$18,405,189
Attributed
$18,405,189
Total exposure
40
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,405,189 · 40
By mechanism
R01$16,480,085 · 4
R21$891,000 · 2
P51$881,104 · 33
R03$153,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Donna M Platt$886,300
Others in their field
Top investigators on “Benzodiazepines”
- Sharon L. Walsh · University Of Kentucky$85,160,878
- Andrew S Huhn · Johns Hopkins University$15,128,849
- Manish Ishwar Shah · Baylor College Of Medicine$13,432,895
- Jaideep Kapur · University Of Virginia$11,912,351
- Stephen J Moss · University Of Pennsylvania$11,853,601
- Martha Aq Curley · Children'S Hospital Boston$11,829,990
Research focus
BenzodiazepinesPharmaceutical PreparationsMacaca MulattaReceptorGrantLigandsAnti-Anxiety AgentsModern MedicineMuscle RelaxantsDiazepamHypnoticAnticonvulsantsDrug PrescriptionsSelf AdministrationProceduresAgonistBasePrimatesBehavioralAdverse EffectsMental DisordersPlayPsychotropic DrugsMediating
Grant awards (88)
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$502,789
R01 · FY2025 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$502,789
R01 · FY2024 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$407,436
R01 · FY2024 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$464,186
R01 · FY2023 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$407,436
R01 · FY2023 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$407,436
R01 · FY2022 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$402,717
R01 · FY2021 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$385,116
R01 · FY2021 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$468,631
R01 · FY2020 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$402,717
R01 · FY2020 · DA · contact PI
EEG Telemetry in Monkeys: Potential Markers of Benzodiazepine Action$155,000
R21 · FY2020 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$402,717
R01 · FY2019 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$277,550
R01 · FY2019 · DA · contact PI
EEG Telemetry in Monkeys: Potential Markers of Benzodiazepine Action$271,250
R21 · FY2019 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$588,097
R01 · FY2018 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$277,550
R01 · FY2018 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$152,498
R01 · FY2018 · DA · contact PI
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment$497,519
R01 · FY2017 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$277,550
R01 · FY2017 · DA · contact PI
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation$418,050
R01 · FY2016 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$274,774
R01 · FY2016 · DA · contact PI
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation$415,938
R01 · FY2015 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$346,938
R01 · FY2015 · DA · contact PI
Novel GABA-A Modulators as Cognitive Enhancers$485,263
R01 · FY2014 · AG · contact PI
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation$422,273
R01 · FY2014 · DA · contact PI
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation$457,292
R01 · FY2013 · DA · contact PI
Novel GABA-A Modulators as Cognitive Enhancers$435,384
R01 · FY2013 · AG · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$317,425
R01 · FY2013 · DA · contact PI
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation$57,344
R01 · FY2013 · DA · contact PI
Novel GABA-A Modulators as Cognitive Enhancers$44,618
R01 · FY2013 · AG · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$2,471
R01 · FY2013 · DA · contact PI
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation$602,236
R01 · FY2012 · DA · contact PI
Novel GABA-A Modulators as Cognitive Enhancers$508,598
R01 · FY2012 · AG · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$333,224
R01 · FY2012 · DA · contact PI
Novel GABA-A Modulators as Cognitive Enhancers$509,239
R01 · FY2011 · AG · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$333,224
R01 · FY2011 · DA · contact PI
THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS$13,769
P51 · FY2011 · RR · contact PI
COGNITION AND NEUROPATHOLOGY ASSOCIATED WITH TYPE 2 DIABETES$13,753
P51 · FY2011 · RR · contact PI
SEX DIFFERENCES IN THE ABUSE-RELATED EFFECTS OF BENZODIAZEPINES$13,753
P51 · FY2011 · RR · contact PI
NOVEL GABA(A) MODULATORS AS COGNITIVE ENHANCERS$13,753
P51 · FY2011 · RR · contact PI
Novel GABA-A Modulators as Cognitive Enhancers$542,446
R01 · FY2010 · AG · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$343,530
R01 · FY2010 · DA · contact PI
THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS$18,052
P51 · FY2010 · RR · contact PI
SEX DIFFERENCES IN THE ABUSE-RELATED EFFECTS OF BENZODIAZEPINES$18,052
P51 · FY2010 · RR · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$347,000
R01 · FY2009 · DA · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$347,000
R01 · FY2009 · DA · contact PI
IN VITRO AND IN VIVO CHARACTERIZATION OF THE NOVEL BENZODIAZEPINE ANALOG NEP-510$12,721
P51 · FY2009 · RR · contact PI
THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS$12,721
P51 · FY2009 · RR · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$274,816
R01 · FY2008 · DA · contact PI
THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS$10,820
P51 · FY2008 · RR · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$280,425
R01 · FY2007 · DA · contact PI
ROLE OF GABA(A) RECEPTOR EFFICACY IN BENZODIAZEPINE SELF-ADMINISTRATION$5,301
P51 · FY2007 · RR · contact PI
ENHANCED SUCROSE PELLET CONSUMPTION BY BENZODIAZEPINE-TYPE DRUGS$5,285
P51 · FY2007 · RR · contact PI
DOPAMINE RECEPTORS AND SPEEDBALL ABUSE$5,285
P51 · FY2007 · RR · contact PI
EFFECT OF RELOCATION ON NIGHTTIME ACTIVITY AND STRESS RESPONSES IN MACAQUES$5,285
P51 · FY2007 · RR · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$288,801
R01 · FY2006 · DA · contact PI
REDUCING THE EFFECTS OF A PHARMACOLOGICAL STRESSOR IN MONKEYS$27,966
P51 · FY2006 · RR · contact PI
PRIMATE MODEL OF BENZODIAZEPINE ANXIOLYSIS$27,966
P51 · FY2006 · RR · contact PI
BEHAVIORAL AND REINFORCING EFFECTS OF ALPRAZOLAM IN MONKEYS$27,966
P51 · FY2006 · RR · contact PI
SELF-ADMINISTRATION AND BEHAVIORAL EFFECTS OF ZOLPIDEM AND MIDAZOLAM$27,966
P51 · FY2006 · RR · contact PI
Anxiolytic Effects and Abuse of BZ Receptor Ligands$295,750
R01 · FY2005 · DA
Primate Model of the Transition to Cocaine Addiction$169,000
R21 · FY2005 · DA
COCAINE-LIKE SUBJECTIVE EFFECTS OF HEROIN: ROLE OF MONOAMINE TRANSPORTERS$12,825
P51 · FY2005 · RR
BCCT DOES NOT ATTENUATE BENZODIAZEPINE-INDUCED SUPPRESSION OF LOCOMOTOR ACTIVITY$12,825
P51 · FY2005 · RR
SELF-ADMINISTRATION OF COCAINE-OPIOID COMBINATIONS$12,825
P51 · FY2005 · RR
THERAPEUTIC AND SIDE EFFECTS OF BENZODIAZEPINES: ROLE OF GABA(A) RECEPTORS$12,825
P51 · FY2005 · RR
ADDICTION-RELATED EFFECTS OF BENZODIAZEPINES$12,825
P51 · FY2005 · RR
Primate Model of the Transition to Cocaine Addiction$295,750
R21 · FY2004 · DA
Anxiolytic Effects and Abuse of BZ Receptor Ligands$253,500
R01 · FY2004 · DA
GABA-A/ALPHA1 RECEPTOR INVOLVEMENT IN THE HYPERPHAGIC$11,895
P51 · FY2004 · RR
ABUSE-RELATED EFFECTS OF BENZODIAZEPINE-TYPE HYPNOTICS$11,895
P51 · FY2004 · RR
BEHAVIORAL EFFECTS OF THE FUNCTIONALLY SELECTIVE GABA-A AGONIST SL651498$11,895
P51 · FY2004 · RR
ANTI-CONFLICT EFFECTS OF BENZODIAZEPINES IN MONKEYS: GABA-A RECEPTOR MECHANISMS$10,444
P51 · FY2003 · RR
ANTAGONISM OF THE ATAXIC EFFECTS OF BENZODIAZEPINE AGONISTS BY BETA-CCT$10,444
P51 · FY2003 · RR
THERAPEUTIC AND SIDE EFFECTS OF BENZODIAZEPINES: GABA-A RECEPTOR MECHANISMS$10,444
P51 · FY2003 · RR
GABA-A/ALPHA5 RECEPTOR MECHANISMS IN THE SUBJECTIVE EFFECTS OF ETHANOL$10,444
P51 · FY2003 · RR
ELUCIDATING BENZODIAZEPINE RECEPTOR MECHANISMS USING ZOLPIDEM AND QH-II-066$10,444
P51 · FY2003 · RR
ANXIOLYTIC EFFECTS AND ABUSE OF BZ RECEPTOR LIGANDS$246,371
R01 · FY2002 · DA
DISTINCTIVE INTEROCEPTIVE EFFECTS OF ALPHA 1 SELECTIVE GABA MODULATOR ZOLPIDEM$111,112
P51 · FY2002 · RR
HEROIN &ITS METABOLITES PARTIALLY MIMIC EFFECTS OF COCAINE$111,112
P51 · FY2002 · RR
Nonhuman Primate Model of Benzodiazepine Relapse$76,500
R03 · FY2002 · DA
ANXIOLYTIC EFFECTS AND ABUSE OF BZ RECEPTOR LIGANDS$239,195
R01 · FY2001 · DA
HEROIN &ITS METABOLITES PARTIALLY MIMIC EFFECTS OF COCAINE$111,112
P51 · FY2001 · RR
DISTINCTIVE INTEROCEPTIVE EFFECTS OF ALPHA 1 SELECTIVE GABA MODULATOR ZOLPIDEM$111,112
P51 · FY2001 · RR
Nonhuman Primate Model of Benzodiazepine Relapse$76,500
R03 · FY2001 · DA
ANXIOLYTIC EFFECTS AND ABUSE OF BZ RECEPTOR LIGANDS$232,226
R01 · FY2000 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF ZOLPIDEM IN SQUIREL MONKEYS$12,106
P51 · FY2000 · RR
COCAINE LIKE EFFECTS OF HEROIN: ACTIVE METABOLITES &OPIOID RECEPTOR MECHANISMS$12,106
P51 · FY2000 · RR